Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asacol Maintenance in Pediatric Ulcerative Colitis
NCT01004185Phase 3Terminated
- Sponsor
- Warner Chilcott
- Start
- Oct 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of Salcrozine in ulcerative colitis (UC) (2 arms), sponsored by Warner Chilcott. Primary endpoint: Treatment Success based on Pediatric Ulcerative Colitis Activity Index at 26 weeks. Started Oct 2009; status: terminated.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01004185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004185.